Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
BYD Co. Ltd

Start price
Target price
Perf. (%)
€21.43
21.12.20
€26.00
03.02.22
-5.69%
10.03.21

Revenue growth > 30% per year expected
Undervalued
Small Risks for its business
Significant cyclical dependencies
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€37.29
21.12.20
€42.00
-3.06%
01.02.21

buy
Volkswagen AG VZO

Start price
Target price
Perf. (%)
€148.40
21.12.20
€200.00
37.67%
16.03.21

High valuation
buy
Mercedes-Benz Group AG

Start price
Target price
Perf. (%)
€56.33
21.12.20
€75.00
26.03%
17.03.21

Known brand
Top 10 in its market
Valuable balance sheet
Revenue decline/stagnation expected
buy
Adobe Inc.

Start price
Target price
Perf. (%)
€411.70
20.12.20
€600.00
20.12.21
19.97%
21.12.21

Well known brand
Very Future proof/growth oriented business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Incyte Corp.

Start price
Target price
Perf. (%)
€72.06
20.12.20
-
20.12.21
-7.02%
21.02.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
Lockheed Martin Corp.

Start price
Target price
Perf. (%)
€291.65
20.12.20
-
20.12.21
12.53%
17.04.21

High dividend yield expected
Undervalued
EBIT growth >5% per year expected
Revenue growth >5% per year expected
buy
Marvell Technology Inc.

Start price
Target price
Perf. (%)
€39.54
19.12.20
€41.00
19.12.21
42.27%
10.10.21

Could be worthwhile Investment >10% per year
Caterpillar Inc.

Start price
Target price
Perf. (%)
€148.38
19.12.20
-
19.12.21
20.57%
26.02.21

High dividend yield expected
Future proof or reliable business model
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Coca-Cola Co.

Start price
Target price
Perf. (%)
€44.16
19.12.20
€47.00
-2.50%
13.03.21

Small Risks for its business
Market Leader or Top 3
Well known brand
Undervalued
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.85
19.12.20
€62.00
22.06.21
7.59%
22.06.21

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
buy
Aegon N.V.

Start price
Target price
Perf. (%)
€3.08
19.12.20
€4.60
19.06.21
15.77%
19.06.21

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
Known brand
buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€196.62
19.12.20
€225.00
23.07.21
6.19%
23.07.21

High dividend yield expected
Top 10 in its market
Higher risks for its business
overvalued
D.R. Horton Inc.

Start price
Target price
Perf. (%)
€60.50
18.12.20
-
18.12.21
33.39%
18.04.21

Revenue growth >5% per year expected
Very positive Cash Flow expected
Top 10 in its market
Could be worthwhile Investment >10% per year
buy
Gazprom ADR

Start price
Target price
Perf. (%)
€4.69
18.12.20
€6.00
18.12.21
36.89%
28.06.21

Market Leader or Top 3
Fair valuation
Very high dividend yield expected
Strong uniques
buy
Lockheed Martin Corp.

Start price
Target price
Perf. (%)
€286.90
18.12.20
€370.00
18.06.21
11.71%
18.06.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Strong uniques
buy
SAP SE

Start price
Target price
Perf. (%)
€104.66
18.12.20
€112.00
18.06.21
3.73%
16.02.21

Standard Investments for future growth
Medium risks for its business
Low dividend yield expected
overvalued
buy
Nagacorp. Ltd

Start price
Target price
Perf. (%)
€1.03
18.12.20
€2.00
18.12.21
-35.10%
19.12.21

Could be very worthwhile Investment >20% year
buy
Adyen NV ADR

Start price
Target price
Perf. (%)
€39.60
18.12.20
€40.00
11.62%
11.02.21

Revenue growth >5% per year expected
Valuable balance sheet
Capable Management
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.01
18.12.20
€45.00
-1.78%
23.12.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.17
18.12.20
€27.00
18.06.21
14.83%
19.01.21

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.01
18.12.20
€34.00
18.12.21
-5.35%
15.03.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Tesla Inc

Start price
Target price
Perf. (%)
€179.00
18.12.20
€66.67
18.12.21
29.81%
15.01.21

Innovative
Higher risks for its business
Probably not worthwhile Investment
Very low/no dividend yield expected
buy
Ford Motor Co.

Start price
Target price
Perf. (%)
€7.34
18.12.20
€12.00
18.12.21
35.66%
29.04.21

Fair valuation
Sustainability is important
Innovative
Growths slower than the competition
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€83.36
18.12.20
€90.00
-3.42%
11.03.21

Could be worthwhile Investment >10% per year
Higher risks for its business